Novel derivatives of the apple-derived flavonoid phloridzin have been found to be potent antioxidants in vitro [I]. The antioxidant action of oestrogens such as 17 P-oestradiol may contribute to their cardioprotective effects [2] . Phloretin the aglycone form of phloridzin has been reported to be oestrogenic [3] and its 3-hydroxy derivative may have enhanced weak oestrogen activity that could enable it to act in a similar cardioprotective manner to the antioxidant antioestrogenlweak oestrogen drug tamoxifen [4] . We have compared the potency of phloridzin and its derivatives as inhibitors of liposomal and microsomal lipid peroxidation to that of 17 P-oestradiol, and their potential as antioxidantloestrogenic cardioprotective agents is discussed. saline (14OmM NaCI, 2.7mM KCI, 16mM Na2HP04, 2.9mM KH2P04) at pH 7.4 at a final concentration of IOmg/ml, followed by sonication. The resulting milky suspension of liposomes was allowed to stand in at 4 "C for 1 hour prior to use [S] .
Rat liver microsomes were prepared from the livers of adult male rats by standard differential-centrifgal techniques as described in [S] .
Liposomal or microsomal lipid peroxidation in the presence of Fe(II1) and ascorbate was measured by the formation of thiobarbituric acid reactive substances as described previously [S] . The reaction mixture (final volume I.Oml) contained either liposomes (1 .Omg in 0. I d phosphate buffered saline at pH 7.4), or microsomes (0.25mg of microsomal protein) phosphate buffered saline pH 7.4 (0.5ml) was used for the liposomal assays and lOmM KH2P04-KOH pH 7.4 for the microsomal assays; 1 Op1 of ethanol or test compound dissolved in the same volume of ethanol was added.
Peroxidation was started by adding aqueous solutions of FeC13 (0. I d ) and ascorbate (0. Iml) to give final concentrations of 100pM of each. The reactions were started by the addition of the ascorbate and incubations were carried out at 37 "C for 20 min (unless stated otherwise). The reactions were terminated by the addition of loop1 of butylated hydroxytoluene (0.2% w/v) dissolved in ethanol to suppress further peroxidation during the heating stage of the thiobarbituric acid reaction.
The amount of lipid peroxidation was determined by the thiobarbituric acid test [S] . HCI (0.5d, 25% v/v) was added to each reaction mixture, followed by 0.5ml of thiobarbituric acid solution (1% w/v in 5OmM sodium hydroxide) and heating at 80°C for 30 min.
The chromogen was extracted with 2ml of butan-1-01 and the AJ3* of the upper (organic) layer was measured. All results were the mean+ SD of 6 separate experiments. The results in table 1 show that in the liposomal model membrane system, only the hydroxylated phloridzin derivatives, 3-hydroxyphloridzin and 3-hydroxyphloretin were more potent as inhibitors of lipid peroxidation than 17 8-oestradiol (by 2-fold and -5-fold respectively). In the microsomal model membrane system only 3-hydroxyphloretin was more effective than 17 P-oestradiol and the extent of enhanced potency increased from -5-fold to -9-fold. Phloretin was -2-fold less potent than 17 P-oestradiol in the liposomal system and was approximately equipotent in the microsomal system, whereas an IC50 value for phloridzin was not reached in either system. These results suggest that although phloridzin itself was not an effective inhibitor of lipid peroxidation in the systems tested, its aglycone form phloretin was as effective as 17 poestradiol in the microsomal system and only 2-fold less potent in the liposomal system. This suggests that dietary phloridzidphloretin may confer similar antioxidant cardioprotective effects to 17 p-oestradiol.
Ox-brain phospholipid was suspended in phosphate buffered
inhibitor of lipid peroxidation than 17 P-oestradiol, in both liposomal and microsomal systems. This suggests it may have a potential use as a food additive or therapeutic agent, which could confer usefl health benefits by combining potent antioxidant ability with weak oestrogenic properties. The enhanced antioxidant properties (and potentially enhanced weak oestrogeniclantioestrogenic properties) of 3-hydroxyphloretin compared to phloretin could thus enable it to mimic the action of the cardioprotective antioestrogen drug tamoxifen (and in particular its more potent 4-hydroxy metabolite) [4] .
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